A revolutionary treatment for cancer patients, Cyberknife Robotic Radiosurgery System is world's first such system, designed to treat tumours of all kinds anywhere in the body. With its unique precision and accuracy, it treats both static and moving lesions/tumors, giving clinicians the power to treat patients non-invasively, with successful outcomes. It has high accuracy & efficacy for treating tumours in the brain and spine. With the CyberKnife System, patients can complete treatment in one to five days, unlike weeks it takes to complete conventional radiation therapy course. As a procedure that involves no incision or anesthesia, the treatment minimizes damage of surrounding tissues. Cyberknife offers a very flexible delivery of radiation, while tracking tumors without using frames. An alternative to other surgical procedures, this world's first whole body dedicated irradiation offers painless treatment, which is not only fast & safe but also reduces hospital stay for patients. In addition, it provides non-surgical option for patients who have inoperable or surgically complex tumors, or who may be looking for an alternate to surgery. CyberKnife system consists of a radiation delivery device, called a linear accelerator (or Linac), which is mounted on a robotic arm. The flexibility of the robotic arm enables the CyberKnife System to deliver precise radiation, with easy access to tumors anywhere in the body including the brain, head and neck, spine, lung, prostate, liver, pancreas, breast and other soft tissues. CyberKnife System also utilizes sophisticated software and advanced imaging to track tumor and patient movement and adjusts the beams of high-dose radiation, to ensure treatment is delivered with high degree of accuracy. Due to this exceptional tracking ability, CyberKnife system eliminates the need for patients to have stabilizing frames bolted to their heads or limit their breathing during treatment. The availability of CyberKnife System at Medanta - The Medicity has not only empowered & enhanced our radiation oncology capabilities, but has also facilitated cure for patients with world's most advanced cancer treatment. Some interesting facts & figures
• FDA provided clearance for the CyberKnife system in 1999 to treat intracranial lesions and in 2001 cleared it for treating lesions anywhere in the body, where radiation is indicated.
• CyberKnife system utilizes real-time image guidance to accurately and continuously target the tumor, automatically correcting for movement of the tumor or patient during treatment.
• CyberKnife System is used to deliver both Stereotactic Radiation also known as radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT). These techniques are well researched and clinically proven.
• CyberKnife system capitalizes on modern robotic technology and enables delivery of high doses of radiation, with exacting sub-millimeter accuracy, sparing healthy tissues.
• CyberKnife treatment is not experimental or investigational and is backed and supported by hundreds of peer-reviewed clinical articles.
